Both Wegovy and copyright are GLP-1 receptor agonists intended to treat type 2 diabetes , and can also aid in shedding pounds. But , Wegovy possesses a unique mechanism of action, affecting both GLP-1 and GIP receptors, potentially resulting in greater glycemic control and more significant weight